CD24 and cancer: Because TNBC tumors display a poor prognosis that is associated to higher chemoresistance and stemness properties compared to luminal breast tumors, we investigated the extent to which inhibition of Cdk2 kinase activity selectively targeted the stem-like CD44+/CD24−/Low subpopulation and restored chemosensitivity of SUM149PT cancer cells.